Table 1.
Selected clinical parameters of the SGLT2i arm vs. the DPP-4i arm after the propensity score matching.
| Parameter | SGLT2i arm | DPP-4i arm | SMD |
|---|---|---|---|
| Number of cases | 18,583 | 18,583 | |
| Female gender, n (%) | 8,900 (47.9) | 8,934 (48.1) | 0.004 |
| Age at diagnosis of DM (mean (SD)) | 54.4 (9.5) | 54.7 (10.8) | 0.030 |
| Age at index date (mean (SD)) | 59.6 (10.0) | 59.8 (11.6) | 0.019 |
| Days from diagnosis to index (mean (SD)) | 1,913 (958) | 1,875 (980) | 0.039 |
| Cancer in the past medical history, n (%) | 1.297 (7.0) | 1.305 (7.0) | 0.002 |
Data are taken from reference 7, an Open Access paper, upon written permission (7).
DM, diabetes mellitus; n, number of cases; SMD, standardized mean difference; SGLT2i, sodium-glucose co-transporter 2 inhibitor; DPP-4i, dipeptidyl peptidase-4 inhibitor.